{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:16:55Z","timestamp":1774577815834,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.xkme.2023.100682","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T12:34:35Z","timestamp":1685450075000},"page":"100682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report"],"prefix":"10.1016","volume":"5","author":[{"given":"Nidal","family":"El Yamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Cote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Riopel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Marcoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Mac-Way","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Philibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Agharazii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2023.100682_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ekir.2020.10.002","article-title":"A\u00a0systematic review of immune checkpoint inhibitor-associated glomerular disease","volume":"6","author":"Kitchlu","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.xkme.2023.100682_bib2","first-page":"135","article-title":"Anti-GBM disease following CTLA4 blockade in a patient with metastatic melanoma","volume":"3","author":"Sammartino","year":"2010","journal-title":"NDT Plus"},{"key":"10.1016\/j.xkme.2023.100682_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2018.05.015","article-title":"Goodpasture\u2019s disease in a patient with advanced lung cancer treated with nivolumab: an autopsy case report","volume":"122","author":"Takahashi","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.xkme.2023.100682_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12882-020-02044-9","article-title":"Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report","volume":"21","author":"Hultin","year":"2020","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100682_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13256-021-02766-w","article-title":"Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report","volume":"15","author":"Kyriazis","year":"2021","journal-title":"J\u00a0Med Case Rep"},{"issue":"8","key":"10.1016\/j.xkme.2023.100682_bib6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ekir.2022.04.089","article-title":"Atypical antiglomerular basement membrane nephritis following immune checkpoint inhibitor","volume":"7","author":"Javaugue","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.xkme.2023.100682_bib7","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ekir.2022.08.020","article-title":"Concomitant anti-GBM glomerulonephritis and acute interstitial nephritis following programmed death receptor-1 blockade with nivolumab","volume":"7","author":"Tani","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.xkme.2023.100682_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI13876","article-title":"CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulo- nephritis","volume":"109","author":"Wu","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.xkme.2023.100682_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1681\/ASN.2004100837","article-title":"CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice","volume":"16","author":"Wolf","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100682_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40425-018-0478-8","article-title":"Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience","volume":"7","author":"Mamlouk","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"4S","key":"10.1016\/j.xkme.2023.100682_bib11","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2023.100682_bib12","article-title":"ANCA-associated vasculitis with anti-GBM disease and two types of tumors: a case report","volume":"8","author":"Li","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.xkme.2023.100682_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13256-020-02614-3","article-title":"Sequential occurrence of microscopic polyangiitis and anti-glomerular basement membrane disease in a patient with small cell lung cancer: a case report","volume":"15","author":"Hayashi","year":"2021","journal-title":"J\u00a0Med Case Rep"},{"issue":"1","key":"10.1016\/j.xkme.2023.100682_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13256-017-1384-2","article-title":"Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report","volume":"11","author":"Ismail","year":"2017","journal-title":"J\u00a0Med Case Rep"},{"issue":"9","key":"10.1016\/j.xkme.2023.100682_bib15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of nintedanib","volume":"58","author":"Wind","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.xkme.2023.100682_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2009-0317","article-title":"Bevacizumab","volume":"15","author":"Kazazi-Hyseni","year":"2010","journal-title":"Oncologist"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:26:00Z","timestamp":1762910760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2590059523000985"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100682","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100682"}}